Retina

321-336 of 340

Effective Treatment Strategies for the Management of Diabetic Macular Edema
Effective Treatment Strategies for the Management of Diabetic Macular Edema
CME/CE
Effective Treatment Strategies for the Management of Diabetic Macular Edema
Nancy Holekamp, MD; Alexander M. Eaton, MD
1.00 credit
- Nancy Holekamp, MD
- Alexander M. Eaton, MD
- Matthew Ohr, MD
- Charles C. Wykoff, MD, PhD
1.00 credit
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy
CME/CE
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy
Allen C. Ho, MD; Brandon G. Busbee, MD
1.00 credit
- Allen C. Ho, MD
- Brandon G. Busbee, MD
- Justis P. Ehlers, MD
- Darius M. Moshfeghi, MD
- John D. Pitcher III, MD
1.00 credit
Management and Treatment of Diabetic Macular Edema After Protocol T [SUPPLEMENT]
Management and Treatment of Diabetic Macular Edema After Protocol T [SUPPLEMENT]
CME/CE
Management and Treatment of Diabetic Macular Edema After Protocol T [SUPPLEMENT]
Rishi P. Singh, MD; Mandeep Brar, MD
1.00 credit
- Rishi P. Singh, MD
- Mandeep Brar, MD
- Mark Dunbar, OD
- John W. Kitchens, MD
1.00 credit
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy [WEBINAR]
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy [WEBINAR]
CME/CE Broadcast Replay
AMD 2016: A Review of Treatment Guidelines and the Role of Appropriate Therapy [WEBINAR]
Brandon Busbee, MD; Justis Ehlers, MD
1.00 credit
- Brandon Busbee, MD
- Justis Ehlers, MD
1.00 credit
DRCR.net Protocol Review
DRCR.net Protocol Review
CME/CE
DRCR.net Protocol Review
R.V. Paul Chan, MD; Jorge Fortun, MD
1.00 credit
- R.V. Paul Chan, MD
- Jorge Fortun, MD
- Geeta A. Lalwani, MD
- Andrew A. Moshfeghi, MD
- Dante Pieramici, MD
- Charles C. Wykoff, MD, PhD
1.00 credit
Management and Treatment of Diabetic Macular Edema after Protocol T
Management and Treatment of Diabetic Macular Edema after Protocol T
CME/CE Broadcast Replay
Management and Treatment of Diabetic Macular Edema after Protocol T
Rishi Singh, MD; Mandeep Brar, MD
1.00 credit
- Rishi Singh, MD
- Mandeep Brar, MD
- Mark Dunbar, OD
- John W. Kitchens, MD
1.00 credit
New Paradigms in the Management and Treatment of Diabetic Macular Edema (March 2016)
New Paradigms in the Management and Treatment of Diabetic Macular Edema (March 2016)
CME/CE
New Paradigms in the Management and Treatment of Diabetic Macular Edema (March 2016)
Pravin U. Dugel, MD; Alexander Eaton, MD
1.00 credit
- Pravin U. Dugel, MD
- Alexander Eaton, MD
- Nancy Holekamp, MD
- Szilárd Kiss, MD.
- Baruch D. Kuppermann, MD, PhD
- Nathan Radcliffe, MD
1.00 credit
Anti-VEGF Therapies and Ocular Systemic Impact Update
Anti-VEGF Therapies and Ocular Systemic Impact Update
CME/CE
Anti-VEGF Therapies and Ocular Systemic Impact Update
Peter K. Kaiser, MD; David S. Boyer, MD
1.00 credit
- Peter K. Kaiser, MD
- David S. Boyer, MD
- John W. Kitchens, MD
1.00 credit
Anti-VEGF Update: When is Switching Patients Acceptable and Preferable?
Anti-VEGF Update: When is Switching Patients Acceptable and Preferable?
CME/CE
Anti-VEGF Update: When is Switching Patients Acceptable and Preferable?
David Eichenbaum, MD; Caroline Baumal, MD
1.00 credit
- David Eichenbaum, MD
- Caroline Baumal, MD
- Victor Gonzalez, MD
- Rahul N. Khurana, MD
- Carl D. Regillo, MD
1.00 credit
AMD, RVO and DME Update: Case Studies in Patient & Practice Management
AMD, RVO and DME Update: Case Studies in Patient & Practice Management
CME/CE
AMD, RVO and DME Update: Case Studies in Patient & Practice Management
Jonathan L. Prenner, MD; K. Bailey Freund, MD
1.00 credit
- Jonathan L. Prenner, MD
- K. Bailey Freund, MD
- Richard S. Kaiser, MD
- Elias Reichel, MD
1.00 credit
Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids
Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids
CME/CE
Current Insight Into Retinal Disease Management: Focus on DME and Intravitreal Corticosteroids
Allen C. Ho, MD; Michael D. Ober, MD
1.00 credit
- Allen C. Ho, MD
- Michael D. Ober, MD
- SriniVas R. Sadda, MD
- Rishi P. Singh, MD
1.00 credit
Retina 2014 – Highlights and Hallmarks
Retina 2014 – Highlights and Hallmarks
CME/CE
Retina 2014 – Highlights and Hallmarks
Rishi P. Singh, MD; Dean Eliott, MD
1.00 credit
- Rishi P. Singh, MD
- Dean Eliott, MD
- Philip Ferrone MD
- Szilárd Kiss, MD.
1.00 credit
AMD, RVO, & DME Update: Case Studies in Patient & Practice Management
AMD, RVO, & DME Update: Case Studies in Patient & Practice Management
CME/CE
AMD, RVO, & DME Update: Case Studies in Patient & Practice Management
Jonathan L. Prenner, MD; Dean Eliott, MD
1.00 credit
- Jonathan L. Prenner, MD
- Dean Eliott, MD
- Carl Regillo, MD
- Chirag P. Shah, MD, MPH
1.00 credit
Anti-VEGF Therapies: Ocular and Systemic Impact
Anti-VEGF Therapies: Ocular and Systemic Impact
CME/CE
Anti-VEGF Therapies: Ocular and Systemic Impact
Peter Kaiser, MD; Thomas Albini, MD
1.00 credit
- Peter Kaiser, MD
- Thomas Albini, MD
- Audina Berrocal, MD
- Ross Lakhanpal, MD
- Andrew Moshfeghi, MD, MBA
- Charles C. Wykoff, MD, PhD
1.00 credit
Intravitreal Steroids: Balancing Effective Use With Intraocular Pressure Control
Intravitreal Steroids: Balancing Effective Use With Intraocular Pressure Control
CME/CE
Intravitreal Steroids: Balancing Effective Use With Intraocular Pressure Control
Pravin U. Dugel, MD; Dennis P. Han, MD
1.00 credit
- Pravin U. Dugel, MD
- Dennis P. Han, MD
- Robert J. Noecker, MD, MBA
- Rishi P. Singh, MD
- Rohit Varma, MD, MPH
1.00 credit
Current Management of Vitreomacular Interface Disorders
Current Management of Vitreomacular Interface Disorders
CME/CE
Current Management of Vitreomacular Interface Disorders
Carl Regillo, MD; Peter K. Kaiser, MD
1.00 credit
- Carl Regillo, MD
- Peter K. Kaiser, MD
1.00 credit

21/7